Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in the UBS Virtual CNS Day on Monday, March 18, 2024 at 2:00 p.m. Eastern Time.
The conference will be held virtually. A live webcast of Acadia's presentation will be accessible on the company's website, Acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation.
About Acadia Pharmaceuticals
Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson's disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at Acadia.com and follow us on LinkedIn and Twitter.
Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced the launch of its Customer Experience Center (CEC) in Brazil. ...
Capital Ophthalmic, a leader in the ophthalmic industry with over four decades of expertise, is proud to announce the launch of their comprehensive Preventative Maintenance Programs. These new offerings underscore Capital Ophthalmic's commitment to...
Product: Meat and vegetable products
Issue: Food - Microbial Contamination - Listeria
Distribution:AlbertaBritish ColumbiaPossibly other provinces and territories
See the affected products and product photos for this recall
SOURCE Canadian Food...
On April 27 and 28 at San Francisco's Brava Theatre, Chacruna Institute for Psychedelic Plant Medicines will host its unmissable spring conference: Psychedelic Culture. This year's theme is Cultivating Roots for Cultural Change. Registration is still...
Product: Gift Chocolate
Issue: Food - Allergen - Milk; Food - Allergen - Soy
Distribution: Ontario, Quebec
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
